← Eichor
Study identifier: NCT03739827 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

Condition: Malignant Solid Tumors · Other Neoplasms Solid Tumors · Pediatric Solid Tumor  ·  Sponsor: National Cancer Institute (NCI)

PhaseN/A
Planned participants10000
Who can joinAll sexes, 4 Weeks to no upper limit
Healthy volunteersYes

About this study

Background: Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors originate from genetic changes, a small percentage of these tumors are familial. Researchers want to study these changes in biological samples from people with rare tumors in order to learn more about how these tumors develop. The information obtained from this study may lead to improved screening, preventive guidelines, and treatments. Objective: To better understand rare cancers and hereditary cancer syndromes. Eligibility: People who have a rare tumor, a family history of a rare tumor, a hereditary cancer syndrome, or a mutation that leads to rare tumors. Design: Participants will be screened with questions about their medical history and/or that of their family members. They will give a saliva sample. Participants who have a tumor will have their medical records and tests reviewed. They will answer questions about their wellbeing and needs. They may provide a tumor tissue sample. Participants may also have: * Physical exam * Clinical photography * Blood, urine, saliva, and stool samples taken * Consultation with specialists * A scan that produces a picture of the body. Either one that uses a small amount of radiation, or one that uses a magnetic field. * Genetic testing/genetic counseling. Participants will be contacted once a year. They will answer updated questions about their medical and family history. Participants will be asked to contact t…

This description comes directly from the study's public registry record.

Talk to the study team

Barbara J Thomas, R.N.  ·  (240) 858-3633  ·  barbara.thomas2@nih.gov

Mary F Wedekind Malone, D.O.  ·  (240) 858-3765  ·  maryfrances.wedekindmalone@nih.gov

Always discuss trial participation with your own doctor first.

Locations (3)

National Institutes of Health Clinical CenterBethesda, Maryland, United StatesRecruiting
Oregon Health and Science UniversityPortland, Oregon, United StatesRecruiting
Texas Children's HospitalHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03739827